GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3076 - 3100 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G75896PD
965
IgG Patient 2 3 mild
G75896PD
165
IgM Patient 2 3 mild
G75896PD
1443
IgA Patient 3 -180 mild
G75896PD
313
IgA Patient 3 11 mild
G75896PD
500
IgG Patient 3 -180 mild
G75896PD
80
IgM Patient 3 -180 mild
G75896PD
161
IgA Patient 3 4 mild
G75896PD
511
IgG Patient 3 11 mild
G75896PD
196
IgG Patient 3 4 mild
G75896PD
175
IgM Patient 3 11 mild
G75896PD
405
IgM Patient 3 4 mild
G75896PD
404
IgA Patient 4 12 mild
G75896PD
988
IgG Patient 4 12 mild
G75896PD
365
IgM Patient 4 12 mild
G75896PD
2119
IgA Patient 1 10 moderate
G76355TG
375
IgA Patient 1 22 moderate
G76355TG
392
IgA Patient 1 6 moderate
G76355TG
375
IgG Patient 1 10 moderate
G76355TG
22
IgG Patient 1 22 moderate
G76355TG
25
IgM Patient 1 10 moderate
G76355TG
46
IgM Patient 1 22 moderate
G76355TG
58
IgG Patient 1 6 moderate
G76355TG
28
IgM Patient 1 6 moderate
G76355TG
57
IgA Patient 2 15 mild
G76355TG
1163

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024